Buradasınız

Anasayfa » Content

RETROPERİTONEAL PARAGANGLİOMA: OLGU SUNUMU

RETROPERITONEAL PARAGANGLIOMA: CASE REPORT

Journal Name:

  • İstanbul Tıp Fakültesi Dergisi

Publication Year:

  • 2012

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
Paragangliomas are rare tumors which progress slowly. Paragangliomas are usually located at aortic bifurcation, foramen jugulare, aortic arch and retroperitoneum. Although abdominal pain is the most common symptom of retroperitoneal paraganglioma, symptoms can differ regarding the hormones secreted. Surgical resection and radiotherapy should be preferred for local treatment. The aim of this study is to present and discuss the approach to the paragangliomas with the light of a case with a 5x4x5 cm mass located between abdominal aorta and vena cava inferior who was receiving treatment for hypertension.
Bookmark/Search this post with
Abstract (Original Language): 
Paraganliomalar nadir görülen ve yavaş büyüyen nöroendokrin tümörlerdir. En sık olarak karotis kommunis arter bifurkasyonu, juguler foramen, aortik ark ve retroperitoneal alanda görülür. Retroperitoneal paragangliomalarda en sık görülen belirti karın ağrısı olmakla birlikte, hormonal açıdan aktif tümörlerde salgılanan hormona bağlı olarak klinik belirtiler değişebilmektedir. Bu tümörlerin lokal tedavisinde cerrahi rezeksiyon ve radyoterapi tercih edilen yöntemlerdir. Bu çalışmada hipertansiyon şikayeti nedeniyle takip ve tedavi altındayken, abdominal aorta ve vena cava inferior arasında yerleşmiş yaklaşık 5x4x5 cm boyutlarda paraganglioma saptanan hasta eşliğinde paragangliomalara yaklaşım irdelenmektedir.
FULL TEXT (PDF): 
PDF icon arastirmax-retroperitoneal-paraganglioma-olgu-sunumu.pdf
  • 1
7-9
  • Turkish

REFERENCES

References: 

1. Bulut AŞ, Aksu FÖ, Öztürk S, Ceyhan K, Erden E, Erdoğan N. Karaciğer metastazı ile prezente olan paraganglioma olgusunda sitolojik özellikler. Ankara Üniversitesi Tıp Fakültesi Mecmuası 56:271-274, 2003.
2. DeVita VT, Hellman S Jr, Rosenborg SA. Cancer Principles and Practice of Oncology. Chapter 29: 841-847, 2003.
3. Erginel T, Salepçi T, Acar H, Erdemir A, Keser S, Olcay E. Paraganglioma: Olgu Sunumu. Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi 23:115-117, 2002.
4. Grant CS. Pheochromocytoma. In. Clark OH, ed(s). Textbook of Endocrine Surgery. 1st ed. Philadelphia: W.B. Saunders 513-528, 1997.
5. Haber S. Retrperitoneal and mediastinal chemodectoma: Report of a case and review of the literature. AJR 92:1029-1041, 1964.
6. Lack EE, Cubial AL, Woodruf JM, Forr HW. Paragangliomas of the head and neck region: A clinical study of 69 patients cancer 39:397-407, 1977.
7. Nap RR, Meinardi JR, van den Berg G, Dullaart RP, de Vries J, Wolffenbuttel BH. Long-term follow-up is indicated after surgery for a phaeochromocytoma. Ned Tijdschr Geneeskd. 150:1045-1049, 2006.
8. Söğütlü G, Ara C, Cinpolat O, Çoban S,Yılmaz S, Kırımlıoğlu V. Retroperitoneal Paraganglioma: Olgu sunumu. İnönü Üniversitesi Tıp Fakültesi Dergisi 10:41-42, 2003.
9. Türkyılmaz A, Aydın Y, Kurt A, Destbil A, Eroğlu A. Paraganglioma Geç Pulmoner Metastaz. The Eurasian Journal of Medicine 39:78-80, 2007.
10. Yurt A, Arda MN, Vardar E. Metastatic pheochromocytoma of the thoracic spinal extradural space case report and review of the literature. Kobej Med Sci 51:49-53, 2005.
11. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 366:665-75, 2005.
12. Erlic Z, Neuman HPH. When should genetic testing be obtained in a patient with pheochromocytoma or paraganglioma? Clinical Endocrinology 70:354-357, 2009.
13. Young, WF Jr, Abboud, AL. Editorial: paraganglioma--all in the family. J Clin Endocrinol Metab 91:790-792, 2006.
14. Karagiannis A, Mikhailidis DP, Athyros VG, Harsoulis. Pheochromocytoma: an update on genetics and management. Endocr Relat Cancer 14:935-956, 2007.
15. Paul A Fitzgerald, Robert E Goldsby, John P Huberty, David C Price, Randall A Hawkins, Janet J Veatch, Filemon Dela Cruz, Thierry M Jahan, Charles A Linker, Lloyd Damon, Katherine K Matthay. Malignant pheochromocytomas and paragangliomas: A phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG). Annals Of The New York Academy Of Sciences 1073:465-490, 2006.

Thank you for copying data from http://www.arastirmax.com